Your skincare manufacturing questions, answered.

Standard BFS commercial pilot production usually starts from 10,000+ units. This gives your team enough physical units to review filling behavior, pack structure, trial-kit usability, channel feedback and scale-up assumptions. A 5,000-unit BFS run is not currently confirmed; written factory approval is required before it can be quoted.

No. BFS projects start from 10,000 units, while conventional bottles and jars are quoted by product, formula and packaging. Traditional ampoules start from 5,000 units. Custom tooling, decoration and pack-out can affect the quotation; confirm the scope for the selected product.

Traditional ampoule projects start from 5,000 units. BFS projects start from 10,000 units; a smaller BFS run is not currently confirmed. Conventional bottle and jar orders have product-specific quotations. These quantities apply to filled skincare projects, not empty packaging or lab samples.

A useful quotation starts with product type, formula status, target format, target fill volume, intended use case, first pilot quantity, target market, launch timeline and any documentation needs. If you are not sure whether BFS ampoules or conventional bottles and jars fit, describe your current package and what you want the pilot to prove. That is enough for an initial format review.

The first project-fit review begins after a usable brief is received. Response and pilot timing depend on formula readiness, packaging route, sample approval, material planning, production scheduling and any stability or documentation work required. Early-stage buyers can start with a format question first, then move into pilot scoping once the use case is clearer.

Yes. Custom review can cover BFS ampoule shape, fill volume, strip or single-unit presentation, secondary packaging, trial kit structure, GWP sample pack-out, private-label direction and conventional bottle or jar packaging. Final customization depends on formula behavior, mold path, packaging materials, target market, pilot quantity and launch timing.

Delivery timing depends on whether the formula is ready, whether NDA formula transfer is needed, whether existing molds can be used, whether custom tooling or secondary packaging is required, and how much stability or documentation review the target market needs. A usable brief helps the team give a realistic schedule instead of a generic lead-time promise.

Post-pilot support can include packaging feedback review, sample pack-out discussion, inspection and documentation reference review, next-run planning, format adjustment suggestions and scale-up routing. The goal is to turn pilot results into a clearer next-order decision, not only to ship the first batch.

Single-dose packaging can help support product concepts that focus on freshness, dose control, portability, and reduced contamination risk after opening. It is especially relevant for active formulations, treatment-style products, and sensitive-skin positioning.

LDPE is one material option, not a requirement for every project. We select the material route around destination-market regulations, brand sustainability goals and formula compatibility. Materials intended to support those goals can be incorporated at a project-specific proportion, subject to sourcing documentation, molding and filling trials, seal integrity and stability validation. The material type, proportion and supporting environmental claims are agreed during project review.

0.5ml–20ml small-dose skincare liquid projects, depending on format and use case. BFS ampoule projects are typically reviewed around 0.5ml–10ml, while larger or special formats should be evaluated separately. Final feasibility depends on mold route, formula behavior, opening experience, secondary packaging, unit economics, shelf presentation and your project's launch channel.

BFS ampoules are usually reviewed for small-dose topical cosmetic and personal-care liquids such as serum, essence, booster, scalp-care liquid, trial-kit liquids, travel-set liquids and professional skincare samples. Suitability depends on viscosity, appearance, compatibility with the selected packaging material, filling behavior, opening design and stability expectations. Formula review is needed before confirming the production route.

Yes. If you already have a formula, Steridose Labs can review it under NDA before detailed technical work begins. The review usually checks viscosity, fill-volume target, packaging-material compatibility, stability assumptions, appearance standards and package-opening requirements. Some formulas can move forward with limited adjustment, while others need modification before a reliable pilot or commercial review can be planned.

Yes. Partner factories and R&D resources can support self-developed skincare liquid concepts, formula adjustment, texture review and project-specific sample work. This is useful for teams that want a turnkey beauty project, private-label route or formula improvement before filling. The final route still depends on formula fit, packaging format, stability work, target market and commercial launch plan.

A glass ampoule is usually a rigid, breakable container that can feel premium but may create handling, shipping and travel-kit friction. A BFS ampoule is formed, filled and sealed in one integrated polymer route. For skincare brands, BFS is often reviewed as a lighter, non-glass pilot option for GWP, travel sets, trial kits and clinic/spa sample channels.

Compare how each pack is opened, handled, transported and dispensed. A polymer BFS ampoule avoids a glass-breaking opening step, but that alone does not establish overall finished-product safety. Formula–container compatibility, seal integrity, stability and instructions must be reviewed for the selected formula, packaging and intended use.

A liquid-filled swab combines a liquid reservoir and applicator in one single-use pack. This is historical format information: swabs and applicators are not part of our current offering. Steridose focuses on BFS skincare OEM/ODM, with traditional ampoules, bottles, jars and blister packs as supplementary options for suitable projects.

Applicators are generally compared when a liquid is applied to a small area, but suitability depends on the liquid and release mechanism. Steridose does not currently offer swabs or applicators. For current projects, ask about BFS ampoules, conventional skincare and coordinated trial kits.

BFS stands for Blow-Fill-Seal. It is a manufacturing process in which the container is formed, filled, and sealed in one enclosed system. For skincare and functional cosmetic products, it is often used for single-dose packaging concepts where hygiene, convenience, and formula protection matter.

In some cases, yes. Because each unit is sealed and used once, the formula does not face the same repeated exposure as a multi-use jar or bottle. Whether a product can be preservative-free still depends on the full formulation and production setup.

Yes. Steridose Labs can support private-label and turnkey beauty partners that want to add BFS ampoules, small-dose skincare liquids, conventional skincare or pilot-kit modules to brand client projects. The partner can keep the client relationship while Steridose Labs supports format review, formula route, pilot planning and manufacturing-fit discussion behind the project.

Start with a document index tied to the proposed production site and legal holder. Confirm certificate scope and validity, the product categories covered, and which sample, compatibility, seal-integrity and batch-release records apply to your project. A general quality-system reference does not establish approval for a specific formula or target market.

Yes. Begin with the product category, intended use, dose and target market. Agree the NDA, authorized recipients and technical review scope before sharing a confidential formula. Detailed facility identity and controlled records are provided at the appropriate qualification stage.

Document scope is agreed during quotation for the destination market and selected production site. Identify labeling, ingredient, testing and importer requirements early. Some documents or external testing require separate work and cost; availability must be confirmed for the specific project.